Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+0.96%
adds when stocks drop
when a holding falls −10%+
Middle response
-2.43%
baseline attrition
Rally response
-4.59%
trims into rallies
when a holding rises +10%+
Top positions · 22
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| EWTXEdgewise Therapeutics, I | $169M | 13.7% | +43.2% | 5.0 yr |
| BNBrookfield Corporation | $141M | 11.5% | +16.5% | 2.8 yr |
| ASMLASML Holding N.V. | $125M | 10.2% | +100.9% | 4.3 yr |
| MIRMMirum Pharmaceuticals, I | $122M | 9.9% | +105.1% | 6.8 yr |
| MPLTMapLight Therapeutics, I | $75M | 6.1% | — | 0.5 yr |
| CRMSalesforce, Inc. | $73M | 5.9% | -30.2% | 4.3 yr |
| CRNXCrinetics Pharmaceutical | $56M | 4.6% | +8.3% | 7.0 yr |
| ELVNEnliven Therapeutics, In | $50M | 4.1% | +99.2% | 1.0 yr |
| PCVXVaxcyte, Inc. | $50M | 4.0% | +53.9% | 5.0 yr |
| PHVSPharvaris N.V. | $49M | 4.0% | +79.9% | 5.3 yr |
| AVBPArriVent BioPharma, Inc. | $45M | 3.6% | +24.8% | 2.3 yr |
| VRDNViridian Therapeutics, I | $39M | 3.2% | +45.1% | 2.3 yr |
| CLDXCelldex Therapeutics, In | $38M | 3.1% | +74.8% | 2.0 yr |
| — | $38M | 3.1% | — | 1.0 yr |
| BMRNBioMarin Pharmaceutical | $37M | 3.0% | -20.1% | 4.0 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology66.4%+19.0pp$819M
Asset Management11.5%-20.9pp$141M
Semiconductors10.2%+1.4pp$125M
Software - Application5.9%+0.1pp$73M
Unknown3.1%+2.8pp$38M
Specialty Retail2.6%-1.3pp$32M
Waste Management0.2%$3M
Software - Infrastructure0.1%+0.0pp$2M
Country
US65.9%-6.2pp
NL14.2%+0.7pp
CA13.8%+3.9pp
Unknown3.1%+2.8pp
CN2.6%-1.3pp
FR0.5%
Top 5: 51.3% · Top 10: 73.9% · Top 25: 100.0%
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.23B | 22 | +40.73% | +17.59% | +23.14% | -0.06B |
| 2025-12-31 | $1.25B | 23 | +21.65% | +17.72% | +3.93% | -0.46B |
| 2025-09-30 | $1.52B | 26 | -2.96% | +17.52% | -20.47% | -0.14B |
| 2025-06-30 | $1.35B | 28 | -7.50% | +14.94% | -22.44% | +0.11B |
| 2025-03-31 | $1.26B | 30 | -16.66% | +8.30% | -24.96% | -0.17B |
| 2024-12-31 | $1.60B | 33 | -1.09% | +24.89% | -25.98% | -0.16B |
| 2024-09-30 | $1.96B | 36 | +31.77% | +36.04% | -4.27% | -0.32B |
| 2024-06-30 | $1.94B | 39 | -1.70% | +24.49% | -26.19% | +0.68B |
| 2024-03-31 | $1.41B | 34 | +22.08% | +29.62% | -7.54% | -0.12B |
| 2023-12-31 | $1.45B | 34 | -0.87% | +26.18% | -27.04% | -0.12B |
| 2023-09-30 | $1.32B | 39 | -20.42% | +21.57% | -41.98% | +0.21B |
| 2023-06-30 | $1.27B | 40 | -12.31% | +19.42% | -31.73% | -0.26B |
| 2023-03-31 | $1.38B | 45 | -37.12% | -7.82% | -29.30% | +0.02B |
| 2022-12-31 | $1.58B | 47 | -3.94% | +7.56% | -11.50% | -0.40B |
| 2022-09-30 | $2.06B | 50 | -3.51% | -4.93% | +1.42% | +0.12B |
| 2022-06-30 | $2.02B | 53 | -20.87% | -16.11% | -4.76% | +0.17B |